Government wanting a price discount for a therapy developed as a result of a public-private research collaboration would be akin to the US exerting a claim on every commercial enterprise that uses the internet because its Defense Department helped create it, according to one venture capital leader.
Venture capital leader warns against impact of government claims over research
September 16, 2019 Latest News
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 6 February
February 6, 2026 - - Podcast -
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News -
Pharmac consults on expanding access to Takeda blood cancer therapy
February 5, 2026 - - Latest News -
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News

